	US 11,841,364 B2
	Method for acquiring information on respiratory infection
Atsushi Nakagawa, Kobe (JP); Takehiro Hasegawa, Kobe (JP); and Kohjin Suzuki, Kobe (JP)
Assigned to SYSMEX CORPORATION, Kobe (JP)
Filed by SYSMEX CORPORATION, Kobe (JP)
Filed on Oct. 22, 2021, as Appl. No. 17/507,867.
Claims priority of application No. 2020-177439 (JP), filed on Oct. 22, 2020.
Prior Publication US 2022/0128548 A1, Apr. 28, 2022
Int. Cl. G01N 33/543 (2006.01); A61K 45/06 (2006.01); G01N 33/58 (2006.01)

CPC G01N 33/54326 (2013.01) [A61K 45/06 (2013.01); G01N 33/581 (2013.01); G01N 2800/12 (2013.01); G01N 2800/347 (2013.01); G01N 2800/50 (2013.01); G01N 2800/60 (2013.01)]

12 Claims

1. A method for acquiring information on respiratory infection of a subject and treating the subject, the method comprising:

measuring CXC chemokine ligand 9 (CXCL9) in a specimen collected from the subject suffering from a respiratory infection, or from the subject suspected of having the respiratory infection;

determining a risk of causing acute kidney injury following respiratory infection, on the basis of a measured value of CXCL9, and

treating the subject who is determined to have high risk of acute kidney injury with at least one medical intervention selected from the group consisting of administration of a drug, dialysis, surgery, immunotherapy, and gene therapy.